Divi's Laboratories Future Growth

Future criteria checks 4/6

Divi's Laboratories is forecast to grow earnings and revenue by 24.1% and 15% per annum respectively. EPS is expected to grow by 22% per annum. Return on equity is forecast to be 17.1% in 3 years.

Key information

24.1%

Earnings growth rate

22.0%

EPS growth rate

Life Sciences earnings growth	24.6%
Revenue growth rate	15.0%
Future return on equity	17.1%
Analyst coverage	Good
Last updated	28 May 2024

Recent future growth updates

Recent updates

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Apr 19

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 21

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Jul 07

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Jul 03

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Apr 03

Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

Dec 23

With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Sep 02

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching

Mar 25

Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Mar 10

Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Feb 23

Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?

Jan 25

Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jan 07

Earnings and Revenue Growth Forecasts

NSEI:DIVISLAB - Analysts future estimates and past financials data (INR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2027	120,918	30,035	17,336	N/A	10
3/31/2026	105,289	25,643	11,606	N/A	25
3/31/2025	90,807	20,726	7,605	N/A	27
3/31/2024	76,829	15,405	9,118	N/A	24
12/31/2023	74,926	13,834	N/A	N/A	N/A
9/30/2023	73,456	13,314	7,927	15,127	N/A
6/30/2023	72,906	14,774	N/A	N/A	N/A
3/31/2023	77,676	18,234	19,867	24,597	N/A
12/31/2022	83,353	23,971	N/A	N/A	N/A
9/30/2022	91,208	29,925	22,153	28,404	N/A
6/30/2022	92,538	31,054	N/A	N/A	N/A
3/31/2022	89,599	29,605	11,986	19,118	N/A
12/31/2021	82,297	25,678	N/A	N/A	N/A
9/30/2021	74,379	21,362	4,760	13,465	N/A
6/30/2021	71,996	20,493	N/A	N/A	N/A
3/31/2021	69,695	19,843	10,367	19,469	N/A
12/31/2020	65,710	18,705	N/A	N/A	N/A
9/30/2020	62,658	17,590	10,714	20,167	N/A
6/30/2020	59,620	15,962	N/A	N/A	N/A
3/31/2020	53,945	13,765	327	12,159	N/A
12/31/2019	52,719	12,803	N/A	N/A	N/A
9/30/2019	52,356	13,106	-3,430	7,962	N/A
6/30/2019	51,139	13,575	N/A	N/A	N/A
3/31/2019	49,463	13,527	2,212	9,543	N/A
3/31/2018	38,915	8,770	5,020	7,759	N/A
3/31/2017	40,643	10,604	N/A	11,504	N/A
3/31/2016	37,764	11,258	N/A	10,379	N/A
3/31/2015	31,049	8,515	N/A	8,263	N/A
3/31/2014	25,267	7,733	N/A	5,567	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DIVISLAB's forecast earnings growth (24.1% per year) is above the savings rate (6.7%).

Earnings vs Market: DIVISLAB's earnings (24.1% per year) are forecast to grow faster than the Indian market (15.8% per year).

High Growth Earnings: DIVISLAB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: DIVISLAB's revenue (15% per year) is forecast to grow faster than the Indian market (9.5% per year).

High Growth Revenue: DIVISLAB's revenue (15% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DIVISLAB's Return on Equity is forecast to be low in 3 years time (17.1%).

Divi's Laboratories Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Price target increased by 11% to ₹3,806

Consensus EPS estimates fall by 10%

Price target increased by 7.3% to ₹3,325

Consensus EPS estimates fall by 15%

Consensus EPS estimates fall by 12%

Price target decreased to ₹3,582

Recent updates

Insider recently sold ₹238m worth of stock

Dividend of ₹30.00 announced

Price target increased by 11% to ₹3,806

Divi's Laboratories Limited Recommends A Final Dividend for the Financial Year 2023-24

Divi's Laboratories Limited to Report Q4, 2024 Results on May 25, 2024

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)

Insider recently sold ₹24m worth of stock

Chief Technologist recently sold ₹56m worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q3, 2024 Results on Feb 10, 2024

Insider recently sold ₹59m worth of stock

Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Non-Executive Independent Director recently sold ₹1.4m worth of stock

Consensus EPS estimates fall by 10%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently sold ₹3.3m worth of stock

Chief Technologist recently sold ₹2.9m worth of stock

Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2023

Divi's Laboratories Limited Informs Resignations of Directors

Price target increased by 7.3% to ₹3,325

New minor risk - Profit margin trend

Insufficient new directors

Divi's Laboratories Limited to Report Q1, 2024 Results on Aug 14, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ₹30.00 per share at 0.8% yield

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

New minor risk - Insider selling

Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00

Divi's Laboratories Limited, Annual General Meeting, Aug 28, 2023

Insider recently sold ₹3.4m worth of stock

Divi's Laboratories Limited Recommends a Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹68.69 (vs ₹112 in FY 2022)

Divi's Laboratories Limited to Report Q4, 2023 Results on May 20, 2023

Insider recently sold ₹2.0m worth of stock

Global Quality Head recently sold ₹2.3m worth of stock

Global Quality Head recently sold ₹2.8m worth of stock

Global Quality Head recently sold ₹28m worth of stock

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 15%

Divi's Laboratories Limited to Report Q3, 2023 Results on Feb 03, 2023

Board Member recently sold ₹10m worth of stock

MD & Executive Director recently sold ₹1.0m worth of stock

Insider recently sold ₹1.7m worth of stock

Insider recently sold ₹1.2m worth of stock

Consensus EPS estimates fall by 12%

Price target decreased to ₹3,582

Price target decreased to ₹3,685

Price target decreased to ₹3,685

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Insider recently sold ₹1.5m worth of stock

Insider recently sold ₹3.7m worth of stock

Upcoming dividend of ₹30.00 per share

Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00

Divi's Laboratories Limited to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Divi's Laboratories Limited Recommends Dividend

Divi's Laboratories Limited, Annual General Meeting, Aug 22, 2022

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Insider recently sold ₹2.5m worth of stock

Insider recently sold ₹7.3m worth of stock

Divi's Laboratories Limited Recommends A Dividend for the Year 2021-2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories Limited to Report Q4, 2022 Results on May 23, 2022